Yolonda L. Colson
From EverybodyWiki Bios & Wiki
Yolonda Lorig Colson, MD, PhD is a thoracic surgeon, working in Boston, who is the first female president of the American Association for Thoracic Surgery (AATS).[1] She assumed her current role as the 103rd president of the AATS on May 26, 2022, succeeding Shaf Keshavjee, MD. Colson is the Chief of the Division of Thoracic Surgery at Massachusetts General Hospital,[2] Hermes C. Grillo Professor in Thoracic Surgery, and Professor of Surgery at Harvard Medical School. Colson is an Officer and Exam Chair for the American Board of Thoracic Surgery.[3] She is also a collaborator of the Grinstaff Group.[4]
| Dr. Yolonda L. Colson | |
|---|---|
 Dr Colson at MGH.jpg Colson (center) intraoperatively teaching a Harvard Medical School general surgery resident (Danny Wang, left) and medical student (Jason Thomas, right) at Massachusetts General Hospital | |
| Born | |
| 🏫 Education | Mayo Medical School (MD)
University of Pittsburgh School of Medicine (PhD and surgery residency) Harvard Medical School Brigham and Women's Hospital (fellowship in cardiothoracic surgery) |
| 💼 Occupation | |
| Known for | First female president of the American Association for Thoracic Surgery |
Education and Training
Colson completed her Bachelor of Science (B.S.) in Biomedical Engineering from Rensselaer Polytechnic Institute, Doctor of Medicine (M.D.) from Mayo Medical School, and Doctor of Philosophy (Ph.D.) and general surgery residency at the University of Pittsburg.[5] She then completed a fellowship in cardiothoracic surgery at Brigham and Women's Hospital.
Grants
Colson has been awarded many R29 and R01 NIH and NCI grants:
- Biodegradable, Biocompatible Pressure Sensitive Adhesives (2022[6])
- Supratherapeutic PTX Buttresses Reduce Locoregional Recurrence Rates Following Surgery for Soft Tissue Sarcomas (2022[7])
- Optimization Of Nanoparticle Tumor-Localization And Drug-Loadingfor Treating Mesothelioma (2022[8], 2021[9], 2020[10])
- Tumor Specific Delivery Of Verticillin A Overcomes Epigenetic Silencing Responsible For Drug Resistance (2022[11], 2021[12], 2020[13], 2019[14], 2018[15])
- Superhydrophobic Drug Loaded Buttresses For Prevention Of Lung Tumor Recurrence (2022[16], 2021[17], 2020[18], 2019[19])
- Precise tumor targeting with logic CAR circuits (2022[20], 2021[21])
- Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma (2019[22], 2018[23], 2017[24], 2016[25])
- Flexible, Conformal, Polymeric Films for Lung Resection Margins (2014[26], 2013[27], 2012[28], 2011[29])
- Innovative Clinical Pathways in Lung Cancer Care for Vulnerable Populations (2012[30])
- NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases (2011[31], 2010[32], 2009[33], 2008[34])
- Mechanism of Facilitating Cell-Mediated Tx Tolerance (2007[35], 2006[36], 2005[37], 2004[38][39], 2003[40])
- Facilitating Cell Induced Tolerance In Organ Transplants (2001[41], 2000[42], 1999[43], 1998[44], 1997[45])
Colson also received over twenty AATS foundation grants.[1]
Awards and Recognitions
Awards
- 103rd president of the American Association for Thoracic Surgery (AATS)[1]
- George H.A. Clowes, Jr. Research Career Development Award from the American College of Surgeons (ACS) (2006-2011)[46]
- Edward M. Kennedy Award for Health Care Innovation from CIMIT[3]
- First recipient of Michele Kessler Leadership Award in Women's Health (2006)[47]
- AATS Alton Ochsner Research Scholarship[48]
- Above and Beyond Award, Employer Support of the Guard and Reserve, US (2009)[citation needed]
- Maxwell Resident Career-Research Award (1998-1999)[citation needed]
Recognitions
In 2010 Colson was recognized by the Lung Cancer Alliance for her work "Out of the Shadows", a women's health policy and advocacy program regarding lung cancer in women.[49] In 2020 Colson was interviewed by CTSNet after she was elected as the Vice President of the AATS.[50] Colson is mentioned several Castle Connolly Medical publications.[51][52][53][54]
AATS Appointments[1]
- AATS Membership Committee
- AATS Scientific Affairs and Government Relations Committee
- AATS Foundation Board of Directors
- AATS Chair of the Advisory Council for the AATS Foundation
- Co-chair of the 2015 AATS Annual Meeting
Other Accomplishments
Colson is a co-inventor on six patents.[55][56][57][58][59][60] She founded the Women's Lung Cancer Forum.[61] She is the author of many journal articles and textbook chapters, including the text "Adult Chest Surgery".[62]
References
- ↑ 1.0 1.1 1.2 1.3 "Yolonda L. Colson Assumes Presidency of the American Association for…". AATS. Retrieved 2022-09-01.
- ↑ "Member News: Spring 2019 | STS". www.sts.org. Retrieved 2022-09-05.
- ↑ 3.0 3.1 Lawton, Jennifer S (2021). "A historic event: The first female officer of the American Association for Thoracic Surgery". Journal of Thoracic and Cardiovascular Surgery. 161 (3): 730–732. doi:10.1016/j.jtcvs.2020.06.079. PMC 7335416 Check
|pmc=value (help). PMID 32741627 Check|pmid=value (help). - ↑ "Collaborators". THE GRINSTAFF GROUP. Retrieved 2022-09-05.
- ↑ "Yolonda Colson, MD, PhD - Thoracic Surgery". Massachusetts General Hospital. Retrieved 2022-09-01.
- ↑ "Biodegradable, Biocompatible Pressure Sensitive Adhesives". 2022.
- ↑ "Supratherapeutic PTX Buttresses Reduce Locoregional Recurrence Rates Following Surgery for Soft Tissue Sarcomas". 2022.
- ↑ "OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMA". 2022.
- ↑ "OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADING FOR TREATING MESOTHELIOMA". 2021.
- ↑ "OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADING FOR TREATING MESOTHELIOMA". 2020.
- ↑ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2022.
- ↑ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2021.
- ↑ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2020.
- ↑ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2019.
- ↑ "TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE". 2018.
- ↑ "SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE". 2022.
- ↑ "SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE". 2021.
- ↑ "SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE". 2020.
- ↑ "SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE". 2019.
- ↑ "Precise tumor targeting with logic CAR circuits". 2022.
- ↑ "Precise tumor targeting with logic CAR circuits". 2021.
- ↑ "Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma". 2019.
- ↑ "Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma". 2018.
- ↑ "Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma". 2017.
- ↑ "Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma". 2016.
- ↑ "Flexible, Conformal, Polymeric Films for Lung Resection Margins". 2014.
- ↑ "Flexible, Conformal, Polymeric Films for Lung Resection Margins". 2013.
- ↑ "Flexible, Conformal, Polymeric Films for Lung Resection Margins". 2012.
- ↑ "Flexible, Conformal, Polymeric Films for Lung Resection Margins". 2011.
- ↑ "Innovative Clinical Pathways in Lung Cancer Care for Vulnerable Populations". 2012.
- ↑ "NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases". 2011.
- ↑ "NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases". 2010.
- ↑ "NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases". 2009.
- ↑ "NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases". 2008.
- ↑ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2007.
- ↑ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2006.
- ↑ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2005.
- ↑ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2004.
- ↑ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2004.
- ↑ "Mechanism of Facilitating Cell-Mediated Tx Tolerance". 2003.
- ↑ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 2001.
- ↑ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 2000.
- ↑ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 1999.
- ↑ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 1998.
- ↑ "FACILITATING CELL INDUCED TOLERANCE IN ORGAN TRANSPLANTS". 1997.
- ↑ "Past ACS Scholarship Awardees". ACS. Retrieved 2022-09-12.
- ↑ "BWH Bulletin". www.bwhpublicationsarchives.org. Retrieved 2022-09-17.
- ↑ "AATS Research Scholarship Awardees". AATS. Retrieved 2022-09-17.
- ↑ Alliance, Lung Cancer. "Lung Cancer Alliance Applauds New Report Bringing Lung Cancer in Women Out of the Shadows". www.prnewswire.com. Retrieved 2022-09-05.
- ↑ Antonoff, Mara (2022). "Dr Yolonda Colson, Leading the Future of CT Surgery". doi:10.25373/ctsnet.12631886.
- ↑ "Dr. Yolonda L. Colson - Thoracic & Cardiac Surgery - Boston, MA". Castle Connolly. Retrieved 2022-09-17.
- ↑ America's top doctors : the best in American medicine : America's trusted source for identifying top doctors. Castle Connolly Medical Ltd (12th ed.). New York, N.Y.: Castle Connolly. 2013. ISBN 978-1-883769-63-5. OCLC 812781032. Search this book on
- ↑ America's top doctors : the best in American medicine : America's trusted source for identifying top doctors. Castle Connolly Medical Ltd (13th ed.). New York, N.Y.: Castle Connolly. 2014. ISBN 978-1-883769-68-0. OCLC 871345615. Search this book on
- ↑ America's top doctors : America's trusted source for identifying top doctors. Castle Connolly Medical Ltd (14th ed.). New York. 2015. ISBN 978-1-935036-01-2. OCLC 903146902. Search this book on
- ↑ 6013519, Ildstad, Suzanne T.; Christina Kaufman & Yolanda Colson, "United States Patent: 6013519 - Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells", issued January 11, 2000
- ↑ 10251841, Grinstaff, Mark W.; Aaron H. Colby & Yolonda Colson, "United States Patent: 10251841 - Polymeric depots for localization of agent to biological sites", issued April 9, 2019
- ↑ 7671095, Colson, Yolonda; Solomon Azouz & Mark Grinstaff et al., "United States Patent: 7671095 - Films and particles", issued March 2, 2010
- ↑ 8334324, Colson, Yolonda L.; Solomon Azouz & Mark W. Grinstaff et al., "United States Patent: 8334324 - Films and particles", issued December 18, 2012
- ↑ 8338492, Colson, Yolonda L.; Solomon Azouz & Mark W. Grinstaff et al., "United States Patent: 8338492 - Films and particles", issued December 25, 2012
- ↑ 8795707, Wolinsky, Jesse; Mark W. Grinstaff & Yolonda L. Colson, "United States Patent: 8795707 - Compliant composites for application of drug-eluting coatings to tissue surfaces", issued August 5, 2014
- ↑ "Women Lung Cancer Forum - Brigham and Women's Hospital". www.brighamandwomens.org. Retrieved 2022-09-12.
- ↑ Adult chest surgery. David J. Sugarbaker, Raphael Bueno, Yolonda L. Colson, Michael T. Jaklitsch, Mark Krasna, Steven J. Mentzer (Second ed.). New York. 2015. ISBN 978-0-07-178189-3. OCLC 883749093. Search this book on
This article "Yolonda L. Colson" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Yolonda L. Colson. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
|
This page exists already on Wikipedia. |
